ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” [Anatol J Cardiol]
Anatol J Cardiol. 2023; 27(1): 56-58 | DOI: 10.14744/AnatolJCardiol.2022.2335

Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease”

Tuncay Güzel1, Adem Aktan2, Raif Kılıç3, Bayram Arslan4, Muhammed Demir5, Mehmet Özbek5, Faruk Ertaş5
1Department of Cardiology, Health Science University, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Türkiye
2Department of Cardiology, Mardin Training and Research Hospital, Mardin, Türkiye
3Department of Cardiology, Diyarlife Hospital, Diyarbakır, Türkiye
4Department of Cardiology, Ergani State Hospital, Diyarbakır, Türkiye
5Department of Cardiology, Faculty of Medicine, Dicle University, Diyarbakır, Türkiye

Tuncay Güzel, Adem Aktan, Raif Kılıç, Bayram Arslan, Muhammed Demir, Mehmet Özbek, Faruk Ertaş. Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease”. Anatol J Cardiol. 2023; 27(1): 56-58

Corresponding Author: Tuncay Güzel
Manuscript Language: English
TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Similar articles PubMed Google Scholar


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper: 0.22
SCImago Journal Rank: 0.348

Quick Search



  1. Home
  2. About
  3. Abstrating and Indexing
  1. Copyright
  2. Aim and Scope
  3. Editorial Board
  1. Instructions for Authors
  2. ICMJE Recommendations
  3. Contact

Copyright © 2023 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media. 
LookUs  &   Online Makale